• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. CC TIBIAL INSERT SZ 3, 9MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. CC TIBIAL INSERT SZ 3, 9MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED Back to Search Results
Model Number CC TIBIAL INSERT SZ 3, 9MM
Medical Device Problem Codes Unstable (1667); Naturally Worn (2988); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Emotional Changes (1831); Failure of Implant (1924); Synovitis (2094); Discomfort (2330); Osteolysis (2377); Ambulation or Postural Difficulties (2544); Joint Laxity (4526); Implant Pain (4561); Insufficient Information (4580); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 01/18/2022
Type of Reportable Event Serious Injury
Event or Problem Description
As reported by legal, that a patient had a right knee optetrak implant date: (b)(6) 2017 with revision date: (b)(6) 2022.Reason for the revision was not reported.No additional information provided.
 
Additional Manufacturer Narrative
Pending investigation.
 
Additional Manufacturer Narrative
H3: based on review of all available information, there is no evidence to suggest that the reported event is related to any design issues.The cause of the subsequent revision cannot be conclusively determined, insufficient information.H7: z-0019-2022.
 
Additional Manufacturer Narrative
As a result of additional information received, the following sections have been updated: b4, g3, h2, and h6.Investigation has been re-opened.Additional information and/or investigation conclusion will be reported within 30 days of receipt.
 
Event or Problem Description
As reported via legal documentation, this patient underwent right total knee replacement surgery on (b)(6) 2017 where he was implanted with a recalled optetrak polyethylene tibial insert.On (b)(6) 2022 they underwent right total knee revision surgery due to accelerated and preventable wear of the optetrak polyethylene tibial insert and loosening of the femoral component, approximately 4 years 8 months after their initial procedure.There is no other patient demographic or medical history available.There is no information on the surgical procedure or patient outcome.There is no device return.There are no photos or other images of the device provided.No additional information is available.
 
Additional Manufacturer Narrative
H6: investigation results - the revision reported was likely the result of both prosthesis wear and an insufficient bond between the femoral component and the bone, which led to aseptic (non-infected) femoral loosening.The extent and root cause of the prosthesis wear and femoral loosening cannot be determined as the device(s) were not returned for evaluation, and images, radiographs, and operative notes were not provided.
 
Additional Manufacturer Narrative
If any further information is obtained that would change or alter any information provided, a supplemental report will be filed accordingly.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional and/or corrected information.The reason for the revision reported cannot be confirmed from the information provided but may be the result of prosthesis wear, instability, and femoral loosening or due to inclusion of the polyethylene in the packaging recall.Potential contributions of user and patient-related considerations to the event could not be assessed as the devices were not available for evaluation and images and radiographs were not provided.If any further information is obtained that would change or alter any information provided, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CC TIBIAL INSERT SZ 3, 9MM
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH, INC.
2320 nw 66th ct
gainesville FL 32653
Manufacturer Contact
kate jacobson
2320 nw 66th ct
gainesville, FL 32653
3523771140
MDR Report Key15334499
Report Number1038671-2022-00993
Device Sequence Number17762023
Product Code JWH
UDI-Device Identifier10885862054241
UDI-Public10885862054241
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K954208
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2022
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date (Section B) 03/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/02/2020
Device Model NumberCC TIBIAL INSERT SZ 3, 9MM
Device Catalogue Number208-23-09
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/12/2022
Supplement Date Received by Manufacturer09/08/2022
04/11/2023
09/07/2023
02/27/2025
03/10/2025
Initial Report FDA Received Date09/01/2022
Supplement Report FDA Received Date09/28/2022
05/03/2023
09/20/2023
02/28/2025
03/11/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/04/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
-
-